Literature DB >> 29891683

Enhanced mRNA delivery into lymphocytes enabled by lipid-varied libraries of charge-altering releasable transporters.

Colin J McKinlay1, Nancy L Benner1, Ole A Haabeth2, Robert M Waymouth3, Paul A Wender3,4.   

Abstract

We report a strategy for generating a combinatorial library of oligonucleotide transporters with varied lipid domains and their use in the efficient transfection of lymphocytes with mRNA in vitro and in vivo. This library is based on amphiphilic charge-altering releasable transporters (CARTs) that contain a lipophilic block functionalized with various side-chain lipids and a polycationic α-amino ester mRNA-binding block that undergoes rearrangement to neutral small molecules, resulting in mRNA release. We show that certain binary mixtures of these lipid-varied CARTs provide up to a ninefold enhancement in mRNA translation in lymphocytes in vitro relative to either a single-lipid CART component alone or the commercial reagent Lipofectamine 2000, corresponding to a striking increase in percent transfection from 9-12% to 80%. Informed by the results with binary mixtures, we further show that CARTs consisting of optimized ratios of the two lead lipids incorporated into a single hybrid-lipid transporter molecule maintain the same delivery efficacy as the noncovalent mixture of two CARTs. The lead lipid CART mixtures and hybrid-lipid CARTs show enhanced lymphocyte transfection in primary T cells and in vivo in mice. This combinatorial approach for rapidly screening mRNA delivery vectors has provided lipid-varied CART mixtures and hybrid-lipid CARTs that exhibit significant improvement in mRNA delivery to lymphocytes, a finding of potentially broad value in research and clinical applications.

Entities:  

Keywords:  combinatorial; gene therapy; immunotherapy; nanoparticle; polyplex

Mesh:

Substances:

Year:  2018        PMID: 29891683      PMCID: PMC6042134          DOI: 10.1073/pnas.1805358115

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  64 in total

1.  T cell-specific siRNA delivery using antibody-conjugated chitosan nanoparticles.

Authors:  Jangwook Lee; Kyoung-Soo Yun; Chang Seon Choi; Seung-Hwa Shin; Hong-Seok Ban; Taiyoun Rhim; Sang Kyung Lee; Kuen Yong Lee
Journal:  Bioconjug Chem       Date:  2012-05-31       Impact factor: 4.774

2.  Dynamic amphiphile libraries to screen for the "fragrant" delivery of siRNA into HeLa cells and human primary fibroblasts.

Authors:  Charlotte Gehin; Javier Montenegro; Eun-Kyoung Bang; Ana Cajaraville; Shota Takayama; Hisaaki Hirose; Shiroh Futaki; Stefan Matile; Howard Riezman
Journal:  J Am Chem Soc       Date:  2013-06-14       Impact factor: 15.419

Review 3.  Gene therapy clinical trials worldwide to 2012 - an update.

Authors:  Samantha L Ginn; Ian E Alexander; Michael L Edelstein; Mohammad R Abedi; Jo Wixon
Journal:  J Gene Med       Date:  2013-02       Impact factor: 4.565

4.  Designed guanidinium-rich amphipathic oligocarbonate molecular transporters complex, deliver and release siRNA in cells.

Authors:  Erika I Geihe; Christina B Cooley; Jeff R Simon; Matthew K Kiesewetter; Justin A Edward; Robyn P Hickerson; Roger L Kaspar; James L Hedrick; Robert M Waymouth; Paul A Wender
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-30       Impact factor: 11.205

Review 5.  mRNA vaccine delivery using lipid nanoparticles.

Authors:  Andreas M Reichmuth; Matthias A Oberli; Ana Jaklenec; Robert Langer; Daniel Blankschtein
Journal:  Ther Deliv       Date:  2016

6.  Boosting Intracellular Delivery of Lipid Nanoparticle-Encapsulated mRNA.

Authors:  Siddharth Patel; N Ashwanikumar; Emily Robinson; Allison DuRoss; Conroy Sun; Kerry E Murphy-Benenato; Cosmin Mihai; Örn Almarsson; Gaurav Sahay
Journal:  Nano Lett       Date:  2017-08-24       Impact factor: 11.189

7.  Polyamine-Mediated Stoichiometric Assembly of Ribonucleoproteins for Enhanced mRNA Delivery.

Authors:  Jiahe Li; Yanpu He; Wade Wang; Connie Wu; Celestine Hong; Paula T Hammond
Journal:  Angew Chem Int Ed Engl       Date:  2017-09-19       Impact factor: 15.336

8.  Modulated protonation of side chain aminoethylene repeats in N-substituted polyaspartamides promotes mRNA transfection.

Authors:  Hirokuni Uchida; Keiji Itaka; Takahiro Nomoto; Takehiko Ishii; Tomoya Suma; Masaru Ikegami; Kanjiro Miyata; Makoto Oba; Nobuhiro Nishiyama; Kazunori Kataoka
Journal:  J Am Chem Soc       Date:  2014-08-25       Impact factor: 15.419

9.  An Orthogonal Array Optimization of Lipid-like Nanoparticles for mRNA Delivery in Vivo.

Authors:  Bin Li; Xiao Luo; Binbin Deng; Junfeng Wang; David W McComb; Yimin Shi; Karin M L Gaensler; Xu Tan; Amy L Dunn; Bryce A Kerlin; Yizhou Dong
Journal:  Nano Lett       Date:  2015-11-06       Impact factor: 11.189

10.  Effects of local structural transformation of lipid-like compounds on delivery of messenger RNA.

Authors:  Bin Li; Xiao Luo; Binbin Deng; JoLynn B Giancola; David W McComb; Thomas D Schmittgen; Yizhou Dong
Journal:  Sci Rep       Date:  2016-02-26       Impact factor: 4.379

View more
  43 in total

Review 1.  Delivering the Messenger: Advances in Technologies for Therapeutic mRNA Delivery.

Authors:  Piotr S Kowalski; Arnab Rudra; Lei Miao; Daniel G Anderson
Journal:  Mol Ther       Date:  2019-02-19       Impact factor: 11.454

2.  Charge-altering releasable transporters enable phenotypic manipulation of natural killer cells for cancer immunotherapy.

Authors:  Aaron J Wilk; Nancy Lynn-Benner Weidenbacher; Rosemary Vergara; Ole A W Haabeth; Ronald Levy; Robert M Waymouth; Paul A Wender; Catherine A Blish
Journal:  Blood Adv       Date:  2020-09-08

3.  Local Delivery of Ox40l, Cd80, and Cd86 mRNA Kindles Global Anticancer Immunity.

Authors:  Ole Audun Werner Haabeth; Timothy R Blake; Colin J McKinlay; Anders A Tveita; Adrienne Sallets; Robert M Waymouth; Paul A Wender; Ronald Levy
Journal:  Cancer Res       Date:  2019-01-28       Impact factor: 12.701

4.  Messenger RNA delivery by hydrazone-activated polymers.

Authors:  Marisa Juanes; Oliver Creese; Paco Fernández-Trillo; Javier Montenegro
Journal:  Medchemcomm       Date:  2019-06-18       Impact factor: 3.597

Review 5.  RNA delivery biomaterials for the treatment of genetic and rare diseases.

Authors:  Weiyu Zhao; Xucheng Hou; Olivia G Vick; Yizhou Dong
Journal:  Biomaterials       Date:  2019-06-20       Impact factor: 12.479

6.  In situ T-cell transfection by anti-CD3-conjugated lipid nanoparticles leads to T-cell activation, migration, and phenotypic shift.

Authors:  Azadeh Kheirolomoom; Aris J Kare; Elizabeth S Ingham; Ramasamy Paulmurugan; Elise R Robinson; Mo Baikoghli; Mohammed Inayathullah; Jai W Seo; James Wang; Brett Z Fite; Bo Wu; Spencer K Tumbale; Marina N Raie; R Holland Cheng; Lisa Nichols; Alexander D Borowsky; Katherine W Ferrara
Journal:  Biomaterials       Date:  2021-12-29       Impact factor: 12.479

7.  Ionizable Lipid Nanoparticle-Mediated mRNA Delivery for Human CAR T Cell Engineering.

Authors:  Margaret M Billingsley; Nathan Singh; Pranali Ravikumar; Rui Zhang; Carl H June; Michael J Mitchell
Journal:  Nano Lett       Date:  2020-02-05       Impact factor: 11.189

8.  A Dual-Function Antibiotic-Transporter Conjugate Exhibits Superior Activity in Sterilizing MRSA Biofilms and Killing Persister Cells.

Authors:  Alexandra Antonoplis; Xiaoyu Zang; Melanie A Huttner; Kelvin K L Chong; Yu B Lee; Julia Y Co; Manuel R Amieva; Kimberly A Kline; Paul A Wender; Lynette Cegelski
Journal:  J Am Chem Soc       Date:  2018-11-14       Impact factor: 15.419

9.  Ionizable lipid nanoparticles encapsulating barcoded mRNA for accelerated in vivo delivery screening.

Authors:  Pedro P G Guimaraes; Rui Zhang; Roman Spektor; Mingchee Tan; Amanda Chung; Margaret M Billingsley; Rakan El-Mayta; Rachel S Riley; Lili Wang; James M Wilson; Michael J Mitchell
Journal:  J Control Release       Date:  2019-10-31       Impact factor: 9.776

10.  mRNA vaccination with charge-altering releasable transporters elicits human T cell responses and cures established tumors in mice.

Authors:  Ole A W Haabeth; Timothy R Blake; Colin J McKinlay; Robert M Waymouth; Paul A Wender; Ronald Levy
Journal:  Proc Natl Acad Sci U S A       Date:  2018-09-10       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.